Guidance

COVID-19 treatments: making a proposal for clinical trials

Guidance for innovators looking to propose coronavirus (COVID-19) treatments for testing in UK clinical trials.

• From: Department of Health and Social Care
• Published: 17 August 2020
• Last updated: 16 December 2020
  Show all updates

  1. 16 December 2020

     Updated guidance to include information on REMAP-CAP, PRINCIPLE and AGILE trials.

  2. 17 August 2020

     First published.

This publication was withdrawn on 25 April 2022

This page has been withdrawn because it’s no longer current. See the COVID-19 Antivirals and Therapeutics Taskforce page for information on the provision of treatments for coronavirus (COVID-19) in the UK.

Documents

[Withdrawn] Guidance: making a proposal for COVID-19 therapeutics clinical trials

HTML

[Withdrawn] Proposal form for entry to COVID-19 therapeutics clinical trials

https://podio.com/webforms/24960299/1831874

Details

This guidance gives information on:

• the UK COVID-19 Therapeutics Advisory Panel (UK-CTAP)
• how innovators can propose new treatments for inclusion in the RECOVERY+, REMAP-CAP, PRINCIPLE or AGILE trials